Biljana Cvetkovski

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Identifying pharmacy medicine-dispensing patterns associated with high risk of asthma and COPD exacerbation: an Australian retrospective cohort study.

Identifying pharmacy medicine-dispensing patterns associated with high risk of asthma and COPD exacerbation: an Australian retrospective cohort study.

Journal: BMJ open

Published: July 29, 2026

ARIA-EAACI 2025: Person-Centred, Digitally Enabled and Artificial Intelligence-Assisted Change Management in Airway Diseases: An OECD Best Practice for Integrated Care for Chronic Diseases.

ARIA-EAACI 2025: Person-Centred, Digitally Enabled and Artificial Intelligence-Assisted Change Management in Airway Diseases: An OECD Best Practice for Integrated Care for Chronic Diseases.

Journal: Clinical and translational allergy

Published: March 12, 2026

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments.

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments.

Journal: Allergy

Published: January 22, 2026

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments.

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments.

Journal: Allergy

Published: August 02, 2025

Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024-2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms.

Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024-2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms.

Journal: Allergy

Published: July 17, 2025

A 21-Practice Evaluation of an Asthma and COPD Quality Improvement Program.

A 21-Practice Evaluation of an Asthma and COPD Quality Improvement Program.

Journal: Journal of asthma and allergy

Published: December 20, 2024

Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence-Assisted ARIA Care Pathways (ARIA 2024).

Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence-Assisted ARIA Care Pathways (ARIA 2024).

Journal: The journal of allergy and clinical immunology. In practice

Published: April 16, 2024

The Path to Diagnosis of Severe Asthma-A Qualitative Exploration.

The Path to Diagnosis of Severe Asthma-A Qualitative Exploration.

Journal: International journal of general medicine

Published: September 08, 2023

The future of allergic rhinitis management: A partnership between healthcare professionals and patients.

The future of allergic rhinitis management: A partnership between healthcare professionals and patients.

Journal: The World Allergy Organization journal

Published: August 27, 2023

Uncovering the Burden of Rhinitis in Patients Purchasing Nonprescription Short-Acting β-Agonist (SABA) in the Community.

Uncovering the Burden of Rhinitis in Patients Purchasing Nonprescription Short-Acting β-Agonist (SABA) in the Community.

Journal: Pharmacy (Basel, Switzerland)

Published: April 27, 2023

Identifying critical inhalation technique errors in Dry Powder Inhaler use in patients with COPD based on the association with health status and exacerbations: findings from the multi-country cross-sectional observational PIFotal study.

Identifying critical inhalation technique errors in Dry Powder Inhaler use in patients with COPD based on the association with health status and exacerbations: findings from the multi-country cross-sectional observational PIFotal study.

Journal: BMC pulmonary medicine

Published: February 01, 2023

The impact of implementing an allergic rhinitis clinical management pathway (AR-CMaP) in the community pharmacy.

The impact of implementing an allergic rhinitis clinical management pathway (AR-CMaP) in the community pharmacy.

Journal: Exploratory research in clinical and social pharmacy

Published: November 21, 2022

Showing 1-12 of 40

Last Updated: 09/26/2026